Pharmacology and Pharmacokinetics of Desmopressin in Haemostatic Disorders
- 1 January 1990
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 2 (S5) , 25-31
- https://doi.org/10.1007/bf03258240
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factorBlood, 1989
- Plasminogen activator inhibitor from human endothelial cells. Purification and partial characterizationEuropean Journal of Biochemistry, 1987
- Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: Reduction in blood product usage with desmopressinJournal of the American College of Cardiology, 1987
- Clinical efficacy of desmopressin acetate for hemostatic control in patients with primary platelet disorders undergoing surgeryAmerican Journal of Hematology, 1987
- Intranasal Administration of Peptides: Nasal Deposition, Biological Response, and Absorption of DesmopressinJournal of Pharmaceutical Sciences, 1986
- Response of Patients with Mild and Moderate Hemophilia A and von Willebrand's Disease to Treatment with DesmopressinAnnals of Internal Medicine, 1985
- REDUCED RESPONSE OF URAEMIC BLEEDING TIME TO REPEATED DOSES OF DESMOPRESSINThe Lancet, 1985
- SHORTENING OF BLEEDING TIME BY 1-DEAMINO-8-D-ARGININE VASOPRESSIN IN VARIOUS BLEEDING DISORDERSThe Lancet, 1984
- DDAVP in Haemophilia and von Willebrand's DiseaseThe Lancet, 1983
- DDAVP: Does the drug have a direct effect on the vessel wall?Thrombosis Research, 1983